Becton, Dickinson and Company (BDX) on Thursday said the U.S. Food and Drug Administration has cleared its EnCor EnCompass Breast Biopsy and Tissue Removal System.
The EnCor EnCompass system is designed to allow clinicians to perform breast biopsy procedures across multiple imaging platforms using a single integrated system.
The device is expected to launch in early 2026.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.